Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net income (loss)	$ 95	$ (653)
Less: Loss from discontinued operations, net of taxes	(8)	(17)
Net income (loss) from continuing operations	103	(636)
Adjustments to reconcile net income (loss) to net cash provided by continuing operating activities:
Depreciation and amortization	94	95
Write-off patents		88
Share-based compensation costs	2	23
Amortization of right of use assets	231	154
Changes in operating assets and liabilities:
Other assets	881	502
Prepaid and other current assets	(196)	433
Accounts payable	(340)	(82)
Accrued expenses and other current liabilities	434	274
Lease liabilities	(266)	(203)
Other non-current liabilities	1	51
Total adjustments	841	1,335
Net cash provided by continuing operating activities	944	699
Net cash used in operating activities	(8)	(13)
Net cash used in discontinued operations	(8)	(13)
Net increase in cash	936	686
Cash and cash equivalents - continuing operations, beginning of period	7,483	5,059
Total cash and cash equivalents, end of period	$ 8,419	$ 5,745

The amount of write-off and impairment of patents.

No definition available.

Name:	txmd_WriteoffAndImpairmentOfPatents
Namespace Prefix:	txmd_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of expense (income); loss (gain); increase (decrease) in liability and (increase) decrease in asset used in operating activity; and cash inflow (outflow) from operating activity, classified as other; in reconciling net income to reflect cash provided by (used in) operating activity when indirect cash flow method is applied.